GATX SR NT 2066 (GMTA) At $26.02 Forms Bottom; Corindus Vascular Robotics (de) (NYSEAMERICAN:CVRS) Shorts Down By 5.19%

Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) Logo

Corindus Vascular Robotics Inc (de) (NYSEAMERICAN:CVRS) had a decrease of 5.19% in short interest. CVRS’s SI was 13.44M shares in June as released by FINRA. Its down 5.19% from 14.17M shares previously. With 1.41 million avg volume, 10 days are for Corindus Vascular Robotics Inc (de) (NYSEAMERICAN:CVRS)’s short sellers to cover CVRS’s short positions. The SI to Corindus Vascular Robotics Inc (de)’s float is 13.25%. The stock decreased 1.24% or $0.01 during the last trading session, reaching $0.78. About 771,985 shares traded. Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) has declined 33.09% since June 14, 2017 and is downtrending. It has underperformed by 45.66% the S&P500. Some Historical CVRS News: ; 11/05/2018 – CORINDUS VASCULAR ROBOTICS INC FILES FOR NON-TIMELY 10-Q – SEC FILING; 16/03/2018 – CORINDUS REPORTS $25M PLACEMENT; 23/04/2018 – Corindus Presents “Optimizing Care with CorPath GRX: Hot Topics in Robotic Interventions” at SCAI 2018 Dinner Symposium on Apri; 19/03/2018 – CORINDUS VASCULAR ROBOTICS INC FILES FOR NON-TIMELY 10-K – SEC FILING; 16/04/2018 – Robert J. Smith, Affiliates Report Stake In Corindus Vascular Robot; 16/03/2018 – CORINDUS PLANS $25M PLACEMENT OF SERIES A CONV PFD SHRS, WTS; 15/03/2018 – CORINDUS VASCULAR ROBOTICS INC CVRS.A : COWEN AND COMPANY RAISES TARGET PRICE TO $2.25 FROM $1.75; 08/05/2018 – CORINDUS VASCULAR ROBOTICS INC QTRLY SHR LOSS $0.08; 14/03/2018 – CORINDUS VASCULAR ROBOTICS INC – QTRLY SHR LOSS $0.04; 20/03/2018 – CORINDUS VASCULAR HOLDER HUDSON REPORTS 14.2% STAKE

GATX Corporation SR NT 2066 (GMTA) formed multiple bottom with $24.46 target or 6.00% below today’s $26.02 share price. GATX Corporation SR NT 2066 (GMTA) has $1.01 billion valuation. The stock decreased 0.50% or $0.13 during the last trading session, reaching $26.02. About 15,257 shares traded or 31.78% up from the average. GATX Corporation SR NT 2066 (NYSE:GMTA) has declined 1.85% since June 14, 2017 and is downtrending. It has underperformed by 14.42% the S&P500.

Corindus Vascular Robotics, Inc. designs, makes, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company has market cap of $147.25 million. The firm offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. It currently has negative earnings. The Company’s CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.